RESPECT3: A Randomized type 1 hybrid Effectiveness-implementation Study of returning actionable genetic PanEl researCh resulTs
RESPECT3: A Randomized type 1 hybrid Effectiveness-implementation Study of returning actionable genetic PanEl researCh resulTs
批准号:
10433830
负责人:
Angela R. Bradbury
金额:
$74.28万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-09-09 至 2026-05-31
关键词:
AddressAffectiveAmerican Society of Clinical OncologyAwardBehaviorClinical ResearchCognitiveConsensusConsentConsolidated Framework for Implementation ResearchDNA LibraryDataDisadvantagedDisclosureEducationEducational InterventionEffectivenessEnvironmentFamily Cancer HistoryFrequenciesFutureGenesGeneticGenetic CounselingGenetic ResearchGoalsGuidelinesHealthHybridsInterventionInvestigationKnowledgeLife StyleMethodsModelingOutcomeParticipantPatient Outcomes AssessmentsPatient-Focused OutcomesPatientsPenetrancePrivatizationProspective cohort studyRandomizedRecommendationResearchRiskSelf-DirectionTelephoneTest ResultTestingbehavioral outcomebiobankchatbotcohortcostdesigneHealtheffectiveness implementation studyevidence based guidelinesfuture implementationgenetic counselorgenetic testinggenetic variantimplementation barriersnext generation sequencingpreferenceprocess evaluationprogramspsychological distresspsychosocialsociodemographic factorssociodemographicstreatment armtreatment as usualuptakevariant of unknown significance
中文摘要
使用库存DNA的大型前瞻性队列研究越来越多地使用下一代测序
(NGS)评估基因、环境和生活方式对健康结果的影响,但NGS也可以
识别可能显著影响研究参与者未来健康的可操作遗传变异
和/或他们的亲戚。如何最好地教育参与者关于他们拒绝或接受研究的选择
结果,如何荣誉接收结果的偏好,以及如何最好地传达结果,特别是在
大的群体仍然未知。在ECOECT研究(R 01 CA 190871:Bradbury)中,我们开发了
使用电子健康教育确立了可行性和有利的患者报告结局,
同意干预作为传统的预披露遗传咨询的替代方案。的目标
建议的竞争性更新是进行混合1型有效性实施研究,以评估
电子健康交付替代方案,用于预先披露教育和可操作的遗传研究结果的返回。
基于ECOECT研究(R 01 CA 190871:Bradbury),我们将调整ECOECT电子健康预处理,
披露干预,为1250名宾夕法尼亚大学生物样本库参与者(625名具有可操作结果,625名对照)提供一个
聊天机器人支持的电子健康教育干预(eHealthED),提供有关益处的信息,
接收研究结果的限制,结果将如何返回,以及他们拒绝接收的选择
结果(目标1)。在目标2中,我们将随机分配具有可操作研究结果的参与者,
通过电话与GC(常规护理)或一个知情的和用户测试的聊天机器人启用电子健康
返回结果干预(eHealthROR)。所有随机分配至eHealthROR的受试者(例如干预组)
在收到结果之前或之后,将提供与GC交谈的选项。与此同时,
我们将进行一项CFIR(实施研究综合框架)知情过程评估
了解电子健康干预使用的调节因素、患者结局、成本以及促进因素和障碍
未来的实施和可持续性使用电子健康干预措施,以返回可操作的遗传
研究结果在大型和社会人口多样化的研究队列(目标3)。我们假设
大多数参与者将获得补充的电子健康和聊天机器人支持的教育,
我们的电子健康干预措施的可操作的研究结果将导致非劣效的短期和纵向
患者的认知、情感和行为结果以及更低的成本,为返回
向大型生物库的研究参与者提供可操作的结果。因此,我们希望这项研究能提供证据-
基于实践指南,将可操作的遗传研究结果返还给参与者。
英文摘要
Large prospective cohort studies with banked DNA have increasingly utilized next generation sequencing
(NGS) to evaluate the effects of genes, the environment and lifestyle on health outcomes, but NGS can also
identify actionable genetic variants that may significantly impact the future health of the research participant
and/or their relatives. How best to educate participants about their options to decline or receive research
results, how to honor preferences for receipt of results, and how to best communicate results, particularly in
large cohorts remains unknown. In the RESPECT studies (R01 CA190871:Bradbury), we have developed and
established the feasibility and favorable patient-reported outcomes with using an eHealth education and
consent intervention as an alternative to traditional pre-disclosure genetic counseling. The goal of the
proposed competitive renewal is to conduct a Hybrid Type 1 effectiveness-implementation study to evaluate
eHealth delivery alternatives for pre-disclosure education and return of actionable genetic research results.
Building upon the RESPECT studies (R01 CA190871: Bradbury), we will adapt our RESPECT eHealth pre-
disclosure intervention to offer 1250 Penn Biobank participants (625 with actionable results and 625 controls) a
chatbot enabled eHealth education intervention (eHealthED) that provides information about the benefits and
limitations of receiving research results, how results will be returned and their options for declining receipt of
results (Aim 1). In Aim 2, we will randomize participants with actionable research results to receive their results
via telephone with a GC (usual care) or a stakeholder-informed and user-tested chat-bot enabled eHealth
return of results intervention (eHealthROR). All participants randomized to eHealthROR (e.g. intervention arm)
will be provided the option to speak with a GC as an alternative, before or after receiving results. Concurrently,
we will conduct a CFIR (Consolidated Framework for Implementation Research)-informed process evaluation
to understand moderators of eHealth intervention usage, patient outcomes, costs and facilitators and barriers
to future implementation and sustainability of using eHealth interventions for return of actionable genetic
research results in large and sociodemographically diverse research cohorts (Aim 3). We hypothesize that the
majority of participants will access supplemental eHealth and chatbot enabled education and that disclosure of
actionable research results by our eHealth intervention will result in non-inferior short-term and longitudinal
patient cognitive, affective and behavioral outcomes and lower costs, providing a scalable model for returning
actionable results to research participants in large biobanks. Thus, we expect this study to inform evidence-
based practice guidelines for return of actionable genetic research results to participants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Delivery of Genetic Services to High Risk Childhood Cancer Survivors: A Randomized Study of Remote Genetic Services Versus Usual Care
-
批准号:10442616
-
项目类别:
-
资助金额:$66.18万
-
财政年份:2020
-
负责人:Angela R. Bradbury
-
依托单位:
Improving Delivery of Genetic Services to High Risk Childhood Cancer Survivors: A Randomized Study of Remote Genetic Services Versus Usual Care
-
批准号:9895399
-
项目类别:
-
资助金额:$76.47万
-
财政年份:2020
-
负责人:Angela R. Bradbury
-
依托单位:
A Randomized Hybrid Type I effectiveness-implementation study of an Ehealth delivery Alternative for Cancer genetic testing for Hereditary cancer predisposition (eREACH)
-
批准号:10265512
-
项目类别:
-
资助金额:$80.02万
-
财政年份:2020
-
负责人:Angela R. Bradbury
-
依托单位:
A Randomized Hybrid Type I effectiveness-implementation study of an Ehealth delivery Alternative for Cancer genetic testing for Hereditary cancer predisposition (eREACH)
-
批准号:10684221
-
项目类别:
-
资助金额:$78.58万
-
财政年份:2020
-
负责人:Angela R. Bradbury
-
依托单位:
A Randomized Hybrid Type I effectiveness-implementation study of an Ehealth delivery Alternative for Cancer genetic testing for Hereditary cancer predisposition (eREACH)
-
批准号:10087243
-
项目类别:
-
资助金额:$81.43万
-
财政年份:2020
-
负责人:Angela R. Bradbury
-
依托单位:
Improving Delivery of Genetic Services to High Risk Childhood Cancer Survivors: A Randomized Study of Remote Genetic Services Versus Usual Care
-
批准号:10212342
-
项目类别:
-
资助金额:$69.43万
-
财政年份:2020
-
负责人:Angela R. Bradbury
-
依托单位:
Returning genetic research panel results for breast cancer susceptibility
-
批准号:8801417
-
项目类别:
-
资助金额:$82.23万
-
财政年份:2014
-
负责人:Angela R. Bradbury
-
依托单位:
Returning genetic research panel results for breast cancer susceptibility
-
批准号:9134444
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2014
-
负责人:Angela R. Bradbury
-
依托单位:
RESPECT3: A Randomized type 1 hybrid Effectiveness-implementation Study of returning actionable genetic PanEl researCh resulTs
-
批准号:10672367
-
项目类别:
-
资助金额:$73.77万
-
财政年份:2014
-
负责人:Angela R. Bradbury
-
依托单位:
Returning genetic research panel results for breast cancer susceptibility
-
批准号:9353730
-
项目类别:
-
资助金额:$59.82万
-
财政年份:2014
-
负责人:Angela R. Bradbury
-
依托单位:
Virtual Cancer Genetic Services: Telemedicine Delivery in Community Clinics
-
批准号:8550792
-
项目类别:
-
资助金额:$17.3万
-
财政年份:2012
-
负责人:Angela R. Bradbury
-
依托单位:
Communicating Genetic Test Results by Telephone: A Randomized Trial
-
批准号:8513942
-
项目类别:
-
资助金额:$57.45万
-
财政年份:2012
-
负责人:Angela R. Bradbury
-
依托单位:
Communicating Genetic Test Results by Telephone: A Randomized Trial
-
批准号:8657915
-
项目类别:
-
资助金额:$64.02万
-
财政年份:2012
-
负责人:Angela R. Bradbury
-
依托单位:
Virtual Cancer Genetic Services: Telemedicine Delivery in Community Clinics
-
批准号:8385447
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2012
-
负责人:Angela R. Bradbury
-
依托单位:
Communicating Genetic Test Results by Telephone: A Randomized Trial
-
批准号:8293769
-
项目类别:
-
资助金额:$66.81万
-
财政年份:2012
-
负责人:Angela R. Bradbury
-
依托单位:
Communicating Genetic Test Results by Telephone: A Randomized Trial
-
批准号:8840818
-
项目类别:
-
资助金额:$58.67万
-
财政年份:2012
-
负责人:Angela R. Bradbury
-
依托单位:
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family Registry
-
批准号:8788253
-
项目类别:
-
资助金额:$57.86万
-
财政年份:2011
-
负责人:Angela R. Bradbury
-
依托单位:
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family Registry
-
批准号:8403666
-
项目类别:
-
资助金额:$61.39万
-
财政年份:2011
-
负责人:Angela R. Bradbury
-
依托单位:
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family Registry
-
批准号:8040734
-
项目类别:
-
资助金额:$67.0万
-
财政年份:2011
-
负责人:Angela R. Bradbury
-
依托单位:
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family Registry
-
批准号:8607512
-
项目类别:
-
资助金额:$76.72万
-
财政年份:2011
-
负责人:Angela R. Bradbury
-
依托单位:
海外基金